These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 19884333)

  • 1. A new generation of stable, nonantibiotic, low-copy-number plasmids improves immune responses to foreign antigens in Salmonella enterica serovar Typhi live vectors.
    Galen JE; Wang JY; Chinchilla M; Vindurampulle C; Vogel JE; Levy H; Blackwelder WC; Pasetti MF; Levine MM
    Infect Immun; 2010 Jan; 78(1):337-47. PubMed ID: 19884333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptation of the endogenous Salmonella enterica serovar Typhi clyA-encoded hemolysin for antigen export enhances the immunogenicity of anthrax protective antigen domain 4 expressed by the attenuated live-vector vaccine strain CVD 908-htrA.
    Galen JE; Zhao L; Chinchilla M; Wang JY; Pasetti MF; Green J; Levine MM
    Infect Immun; 2004 Dec; 72(12):7096-106. PubMed ID: 15557633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced immunity to Plasmodium falciparum circumsporozoite protein (PfCSP) by using Salmonella enterica serovar Typhi expressing PfCSP and a PfCSP-encoding DNA vaccine in a heterologous prime-boost strategy.
    Chinchilla M; Pasetti MF; Medina-Moreno S; Wang JY; Gomez-Duarte OG; Stout R; Levine MM; Galen JE
    Infect Immun; 2007 Aug; 75(8):3769-79. PubMed ID: 17502396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucosal immunization with attenuated Salmonella enterica serovar Typhi expressing protective antigen of anthrax toxin (PA83) primes monkeys for accelerated serum antibody responses to parenteral PA83 vaccine.
    Galen JE; Chinchilla M; Pasetti MF; Wang JY; Zhao L; Arciniega-Martinez I; Silverman DJ; Levine MM
    J Infect Dis; 2009 Feb; 199(3):326-35. PubMed ID: 19099487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel methods for expression of foreign antigens in live vector vaccines.
    Wang JY; Harley RH; Galen JE
    Hum Vaccin Immunother; 2013 Jul; 9(7):1558-64. PubMed ID: 23406777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Live recombinant Salmonella Typhi vaccines constructed to investigate the role of rpoS in eliciting immunity to a heterologous antigen.
    Shi H; Santander J; Brenneman KE; Wanda SY; Wang S; Senechal P; Sun W; Roland KL; Curtiss R
    PLoS One; 2010 Jun; 5(6):e11142. PubMed ID: 20585446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of mchI encoding immunity to the antimicrobial peptide microcin H47 as a plasmid selection marker in attenuated bacterial live vectors.
    Fang CM; Wang JY; Chinchilla M; Levine MM; Blackwelder WC; Galen JE
    Infect Immun; 2008 Oct; 76(10):4422-30. PubMed ID: 18663003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosally delivered Salmonella typhi expressing the Yersinia pestis F1 antigen elicits mucosal and systemic immunity early in life and primes the neonatal immune system for a vigorous anamnestic response to parenteral F1 boost.
    Ramirez K; Capozzo AV; Lloyd SA; Sztein MB; Nataro JP; Pasetti MF
    J Immunol; 2009 Jan; 182(2):1211-22. PubMed ID: 19124765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and immunogenicity of phoP/phoQ-deleted Salmonella typhi expressing Helicobacter pylori urease in adult volunteers.
    DiPetrillo MD; Tibbetts T; Kleanthous H; Killeen KP; Hohmann EL
    Vaccine; 1999 Oct; 18(5-6):449-59. PubMed ID: 10519934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of plasmid maintenance in the attenuated live vector vaccine strain Salmonella typhi CVD 908-htrA.
    Galen JE; Nair J; Wang JY; Wasserman SS; Tanner MK; Sztein MB; Levine MM
    Infect Immun; 1999 Dec; 67(12):6424-33. PubMed ID: 10569759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of immunogenicity and in vivo distribution of Salmonella enterica serovar Typhi and Typhimurium live vector vaccines delivered by mucosal routes in the murine model.
    Pasetti MF; Pickett TE; Levine MM; Sztein MB
    Vaccine; 2000 Aug; 18(28):3208-13. PubMed ID: 10869765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A murine model of intranasal immunization to assess the immunogenicity of attenuated Salmonella typhi live vector vaccines in stimulating serum antibody responses to expressed foreign antigens.
    Galen JE; Gomez-Duarte OG; Losonsky GA; Halpern JL; Lauderbaugh CS; Kaintuck S; Reymann MK; Levine MM
    Vaccine; 1997; 15(6-7):700-8. PubMed ID: 9178472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuated Salmonella enterica serovar Typhi expressing urease effectively immunizes mice against Helicobacter pylori challenge as part of a heterologous mucosal priming-parenteral boosting vaccination regimen.
    Londoño-Arcila P; Freeman D; Kleanthous H; O'Dowd AM; Lewis S; Turner AK; Rees EL; Tibbitts TJ; Greenwood J; Monath TP; Darsley MJ
    Infect Immun; 2002 Sep; 70(9):5096-106. PubMed ID: 12183559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards a human oral vaccine for anthrax: the utility of a Salmonella Typhi Ty21a-based prime-boost immunization strategy.
    Baillie LW; Rodriguez AL; Moore S; Atkins HS; Feng C; Nataro JP; Pasetti MF
    Vaccine; 2008 Nov; 26(48):6083-91. PubMed ID: 18805452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo characterization of the murine intranasal model for assessing the immunogenicity of attenuated Salmonella enterica serovar Typhi strains as live mucosal vaccines and as live vectors.
    Pickett TE; Pasetti MF; Galen JE; Sztein MB; Levine MM
    Infect Immun; 2000 Jan; 68(1):205-13. PubMed ID: 10603389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal and systemic immune responses to chimeric fimbriae expressed by Salmonella enterica serovar typhimurium vaccine strains.
    Chen H; Schifferli DM
    Infect Immun; 2000 Jun; 68(6):3129-39. PubMed ID: 10816454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction, genotypic and phenotypic characterization, and immunogenicity of attenuated DeltaguaBA Salmonella enterica serovar Typhi strain CVD 915.
    Wang JY; Pasetti MF; Noriega FR; Anderson RJ; Wasserman SS; Galen JE; Sztein MB; Levine MM
    Infect Immun; 2001 Aug; 69(8):4734-41. PubMed ID: 11447145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can a 'flawless' live vector vaccine strain be engineered?
    Galen JE; Levine MM
    Trends Microbiol; 2001 Aug; 9(8):372-6. PubMed ID: 11514219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel use of anaerobically induced promoter, dmsA, for controlled expression of fragment C of tetanus toxin in live attenuated Salmonella enterica serovar Typhi strain CVD 908-htrA.
    Orr N; Galen JE; Levine MM
    Vaccine; 2001 Feb; 19(13-14):1694-700. PubMed ID: 11166893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salmonella enterica serovar Typhi live vector vaccines finally come of age.
    Galen JE; Pasetti MF; Tennant S; Ruiz-Olvera P; Sztein MB; Levine MM
    Immunol Cell Biol; 2009 Jul; 87(5):400-12. PubMed ID: 19417771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.